Biomarin Pharmaceutical Inc (BMRN)

BMRN (NASDAQ:Drugs) EQUITY
$127.19
pos +0.00
+0.00%
Today's Range: 125.51 - 127.50 | BMRN Avg Daily Volume: 1,557,000
Last Update: 05/22/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 40.35%
Open: $0.00
Previous Close: $126.88
52 Week Range: $55.36 - $133.54
Oustanding Shares: 160,336,762
Market Cap: 20,343,528,363
6-Month Chart
TheStreet Ratings Grade for BMRN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 12 12
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.47 1.44 1.44
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -118.58
Price Earnings Comparisons:
BMRN Sector Avg. S&P 500
-118.58 0.00 27.11
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
18.40% 126.44% 236.55%
GROWTH 12 Mo 3 Yr CAGR
Revenue 36.90 0.70 0.19
Net Income 0.00 1.49 0.00
EPS 0.00 0.92 0.00
Earnings for BMRN:
EBITDA -0.10B
Revenue 0.75B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $-0.53 $-0.57 $-2.14 $-1.52
Number of Analysts 9 9 12 11
High Estimate $-0.30 $-0.42 $-1.57 $-0.93
Low Estimate $-0.64 $-0.64 $-2.50 $-2.45
Prior Year $-0.19 $-0.16 $-0.77 $-2.14
Growth Rate (Year over Year) -180.12% -257.64% -177.49% 28.73%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Many of these stocks are off to the races.
And it's not the favorable macroeconomic climate.
An answer to those asking me what's worth buying.
You can't help but feel better about both groups.
Here are healthcare stocks of all shares and sizes with strong charts.
Own them, or take something off the table?
A Fed-related dip may be your only hope to get in lower.
These companies are doing great -- take some profits!
It shouldn't be possible, but it never seems too late to get in.
Stocks that stabilized yesterday were terrific today.

Columnist Conversations

There is $1.25 billion to sell market on close as of 347PM.
Goldman Sachs say Yellen is "balanced." Their view is that the Fed Chair downplayed weak 1Q2015 growth and sai...
There was nothing new at all out of Yellen's speech today. She expects rates to rise this year but repeats aga...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.